Teva Obtains Approval For ProAir Digihaler In The US

 
• By Grace Montgomery

Receiving FDA approval for its ProAir Digihaler (albuterol sulfate) inhalation powder is a “significant milestone” for Teva, as the firm reveals plans to make the device available in limited geographies in 2019, with a nationwide US launch set for 2020.

Milestone
Teva hits milestone with ProAir Digihaler approval in US • Source: Shutterstock

More from Products

More from Generics Bulletin